Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder: An exploratory pilot case-control study
Posted by Leanne Kodsman on
Human Plasma with EDTA anticoagulant from Innovative Research was recently used in the following study:
Journal of Affective Disorders, July 2018.
Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder: An exploratory pilot case-control study
Nobuki Kuwano, Takahiro A. Kato, Masato Mitsuhashi, Mina Sato-Kasai, Norihiro Shimokawa, Kohei Hayakawa, Masahiro Ohgidani, Noriaki Sagata, Hiroaki Kubo, Takeshi Sakurai, Shigenobu KanbaJournal of Affective Disorders, July 2018.
"...Since our sandwich ELISA method used a combination of 2 different target antibodies, such as anti-SNAP25 as a capture antibody, and anti-CD81, anti-SYP, anti-IL1beta, anti-IL6, anti-IL34, anti-TNFalpha, anti-TNFR1, or anti-OXR as a detection antibody, a purified or recombinant protein was not applicable as a quantification standard. Thus, we first screened various plasma samples obtained from commercial sources (Innovative Research..."
Related products available from Innovative Research also include:
The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!
Related Posts
Easy as PAI(-1): Celebrate Pi Day with Cutting-Edge Monoclonal Antibodies from Innovative Research
In the ever-evolving landscape of molecular biology, precision tools are essential for ...
Read the ArticleRevolutionizing Diabetes Treatment: Genetically Engineered Pseudo-Islets Achieve Insulin Independence
In a groundbreaking study, researchers have pioneered a diabetes treatment that could r...
Read the ArticlePioneering Advances in Complement-Mediated Disorders: An In-depth Look at SAR443809
In the dynamic landscape of medical research, SAR443809 emerges as a promising candidat...
Read the Article